Clinical Trial Update: Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting results from Regadenoson blood flow assessment in individuals with coronary artery disease and Type 1 diabetes; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 1 Diabetes Mellitus

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Coronary Artery Disease, Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2015-12-14